BioSpace News Archive

BioMidwest

Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D.

Syncromune®, Inc. proudly announces the addition of James Armitage, M.D., to its Scientific Advisory Board as the Advisory Board Chair.

October 31, 2023
·
7 min read
BioMidwest

AtriCure to Participate in the Stifel 2023 Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Stifel 2023 Healthcare Conference.

October 31, 2023
·
1 min read
Drug Development

Epion Therapeutics Initiates Phase 3 Clinical Trials for Minimally-Invasive Keratoconus Treatment

Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy.

October 31, 2023
·
2 min read
BioMidwest

Panbela Announces Validation of European Patent in UK, Italy, Germany, France, and Spain for Claims of a Novel Process for the Production of SBP-101

Panbela Therapeutics, Inc. announced validation for the European patent 2019213664 titled “METHODS FOR PRODUCING -3,8,13,18- TETRAAZAICOSANE-6,15-DIOL” in the United Kingdom, Italy, Germany, France, and Spain.

October 31, 2023
·
8 min read
Pharm Country

Annovis Bio Announces Pricing of $7.5 Million Public Offering

Annovis Bio, Inc. announced the pricing of an underwritten public offering of 1,250,000 units consisting of one share of its common stock and an accompanying warrant.

October 31, 2023
·
4 min read
BioCapital

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Adial Pharmaceuticals, Inc. today announced that the Chief Medical Officer of Adial, Bankole Johnson, D.Sc., M.D., and Key Opinion Leaders will be presenting at The Annual International Society of Addiction Medicine Conference taking place November 2-4, 2023, in Marrakesh, Morocco.

October 31, 2023
·
2 min read
Business

Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update

Scinai Immunotherapeutics Ltd announced the publication today of its financial results for the third quarter ended Sept. 30, 2023 and provided a business update.

October 31, 2023
·
12 min read
Business

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

Journey Medical Corporation announced the Company will release its third quarter 2023 financial results after the U.S. financial markets close on Tuesday, November 7, 2023.

October 31, 2023
·
2 min read
Business

Third Harmonic Bio Announces Leadership Changes

Third Harmonic Bio, Inc. today announced the transition of Adrian S. Ray, Ph.D., from Chief Scientific Officer to Scientific Advisor, effective November 1, 2023.

October 31, 2023
·
3 min read
Drug Development

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

YS Biopharma Co., Ltd. today announced the completion of subject enrollment in its Phase 3 clinical trial (the “Phase 3 Trial” or the “Trial”) of the Company’s PIKA Rabies Vaccine.

October 31, 2023
·
8 min read